0001493152-24-009319.txt : 20240308 0001493152-24-009319.hdr.sgml : 20240308 20240308080725 ACCESSION NUMBER: 0001493152-24-009319 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cundy Kenneth C CENTRAL INDEX KEY: 0001322959 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 24732404 MAIL ADDRESS: STREET 1: 1455 ADAMS DRIVE, SUITE 2050 STREET 2: MENLO BUSINESS PARK CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 4/A 1 ownership.xml X0508 4/A 2024-02-29 2024-03-01 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001322959 Cundy Kenneth C C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEVIEW, TX 78734 0 1 0 0 Chief Scientific Officer 0 Stock Option (right to buy) 2.72 2024-02-29 4 A 0 72613 0 A 2034-02-28 Common Stock 72613 72613 D The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024. *This Form 4 is being filed to amend the exercise price of the stock option /s/ Kenneth C. Cundy 2024-03-08